← Back to Search

Enteric/Micro Order for Menopause (EFE1 Trial)

N/A

Waitlist Available

Research Sponsored by Metagenics, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 14 days

Awards & highlights

EFE1 Trial Summary

This trial compared two different forms of a herbal remedy, to see which was most effective.

EFE1 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 14 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~14 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Gastrointestinal Tolerability

Secondary outcome measures

General Tolerability

EFE1 Trial Design

2Treatment groups

Experimental Treatment

Group I: Micro/Enteric OrderExperimental Treatment2 Interventions

Subjects will receive randomly two distinct formulations of ERr 731® in a 43 day trial consisting of treatment phase 1 (14-days), washout phase (14-days),treatment phase 2 (14-days): Arm 2 will receive micro-coated ERr 731® during treatment phase 1 and enteric coated ERr 731®during treatment phase 2

Group II: Enteric/Micro OrderExperimental Treatment2 Interventions

Subjects will receive randomly two distinct formulations of ERr 731® in a 43 day trial consisting of treatment phase 1 (14-days), washout phase (14-days),treatment phase 2 (14-days): Arm 1 will receive enteric coated ERr 731® during treatment phase 1 and micro-coated ERr 731®during treatment phase 2

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

ERr 731 - Micro-coated

2023

N/A

~20

ERr 731 - Enteric coated

2023

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Metagenics, Inc.Lead Sponsor

14 Previous Clinical Trials

1,401 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this clinical trial open to elderly individuals?

"To be eligible for this study, applicants must fall between the age brackets of 35 to 64. However, there are other studies available for those under 18 and over 65 years old with a total capacity of 28 patients."

Answered by AI

Who has the eligibility to participate in this clinical experiment?

"Eligibility for this medical trial is restricted to women undergoing menopause aged between 35 and 64. A total of 20 patients can be admitted."

Answered by AI

Are there any vacancies to partake in this clinical experiment?

"The data housed on clinicaltrials.gov reveals that this medical experiment, which began recruiting on May 24th 2023 and stopped shortly after July 15th2023, is no longer seeking participants. Fortunately, there are 37 other studies currently accepting volunteers at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ERr 731® Formulation Evaluation

2023. "ERr 731® Formulation Evaluation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05959057.